此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Diagnostic Trial of a Vision Transformer-Based Ultrasound AI Model for Placenta Accreta Spectrum

2026年6月8日 更新者:FANG HE

Diagnostic Trial of Vision Transformer-Based End-to-End Ultrasound Artificial Intelligence Model for Assisting in the Diagnosis of Placenta Accreta Spectrum Disorders: An Investigator-Initiated Prospective Clinical Study

This study develops an end-to-end Vision Transformer (ViT)-based artificial intelligence system for ultrasound-based diagnosis of placenta accreta spectrum (PAS), aiming to improve the accuracy and efficiency of prenatal screening using standardized ultrasound video inputs.

研究概览

详细说明

Placenta accreta spectrum (PAS) is a life-threatening obstetric disorder involving abnormal placental invasion into the uterine wall, which is associated with severe maternal and neonatal complications. Despite advances in imaging, prenatal diagnosis remains challenging due to variability in ultrasound interpretation and reliance on operator expertise.

This study will establish a standardized ultrasound video acquisition protocol and develop a deep learning-based model using Vision Transformer (ViT) architecture to process dynamic ultrasound sequences. The model will be trained using clinically confirmed postpartum outcomes as reference labels.

The diagnostic performance of the system will be systematically evaluated, with the goal of improving consistency in interpretation and supporting more efficient clinical decision-making in prenatal PAS screening.

研究类型

观察性的

注册 (估计的)

561

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习联系方式

学习地点

    • Guangdong
      • Guangzhou、Guangdong、中国、510150
        • 招聘中
        • The Third Affiliated Hospital, Guangzhou Medical University
        • 接触:

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

  • 成人

接受健康志愿者

不

取样方法

非概率样本

研究人群

Pregnant women aged 18-45 years; Gestational age between 24 and 34 weeks; Pregnant women with a history of placenta previa or with an anterior placenta.

描述

Inclusion criteria:

  1. Pregnant women aged between 18 and 45 years;
  2. Gestational age between 24 and 34 weeks;
  3. Pregnant women with a history of placenta previa;
  4. Pregnant women with an anterior placenta;
  5. Willingness to participate in the study and provision of written informed consent.

Exclusion criteria:

  1. Failure to provide written informed consent;
  2. Presence of severe complications that precluded continuation of pregnancy;
  3. Inability to comply with study procedures for other reasons.

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Diagnostic performance of the end-to-end Vision Transformer (ViT)-based ultrasound AI model for placenta accreta spectrum (PAS)
大体时间:At delivery (following confirmation of PAS status by surgical and/or pathological findings)
Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and area under the receiver operating characteristic curve (AUC) of the model.
At delivery (following confirmation of PAS status by surgical and/or pathological findings)

次要结果测量

结果测量
措施说明
大体时间
Clinical Feasibility of the Standardized Ultrasound Video Recording Method
大体时间:At enrollment during the ultrasound examination
Completion Rate (Proportion of patients who successfully complete the standardized recording) and time consumption (Mean recording time)
At enrollment during the ultrasound examination
Consistency and Efficiency Between the AI Model and Physician Diagnosis
大体时间:At enrollment during the ultrasound examination
Diagnostic Consistency: Kappa coefficient used to evaluate the consistency between the AI model's diagnoses and those of experienced ultrasound physicians (Kappa > 0.75 indicates good agreement).
At enrollment during the ultrasound examination
Safety of the AI Model
大体时间:At delivery, when PAS status and maternal outcomes are assessed
False Negative Rate: Proportion of missed PAS-positive patients and the impact on patient outcomes .
At delivery, when PAS status and maternal outcomes are assessed

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

赞助

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2025年9月1日

初级完成 (估计的)

2027年9月1日

研究完成 (估计的)

2027年12月31日

研究注册日期

首次提交

2026年6月2日

首先提交符合 QC 标准的

2026年6月8日

首次发布 (实际的)

2026年6月11日

研究记录更新

最后更新发布 (实际的)

2026年6月11日

上次提交的符合 QC 标准的更新

2026年6月8日

最后验证

2026年6月1日

更多信息

与本研究相关的术语

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

不

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅